Abstract:One of the primary challenges in breast cancer diagnosis and treatment is intratumor heterogeneity (ITH), i.e., the coexistence of different genetically and epigenetically distinct malignant cells within the same tumor. Thus, the identification of ITH is critical for designing better treatments and hence to increase patient survival rates. Herein, we report a noninvasive hybrid imaging technology that integrates multitargeted and multiplexed patchy polymeric photoacoustic contrast agents (MTMPPPCAs) with single-impulse panoramic photoacoustic computed tomography (SIP-PACT). The target specificity ability of MTMPPPCAs to distinguish estrogen and progesterone receptor-positive breast tumors was demonstrated through both fluorescence and photoacoustic measurements and validated by tissue pathology analysis. This work provides the proof-of-concept of the MTMPPPCAs/SIP-PACT system to identify ITH in nonmetastatic tumors, with both high molecular specificity and real-time detection capability.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.0c05893?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.0c05893</a>.Additional experimental data including calculations for in vitro cytotoxicity assessment of MTMPPPCAs (eq 1), encapsulation efficiency of SQ650 and ICG (eq 2), zeta potential measurements (Figure S1), NP size stability studies (Figure S2), and pathology studies (Figures S3–S5) (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05893/suppl_file/nn0c05893_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Exogenous Contrast Agents in Photoacoustic Imaging: An In Vivo Review for Tumor Imaging

Semiconducting Polymer Nanoparticles for Centimeters-Deep Photoacoustic Imaging in the Second Near-Infrared Window

Advancements in photoacoustic imaging for cancer diagnosis and treatment

Biomedical Applications of Photoacoustic Imaging with Exogenous Contrast Agents

Advances in photoacoustic imaging aided by nano contrast agents: special focus on role of lymphatic system imaging for cancer theranostics

Therapeutic and Contrast Agents for Photoacoustic Imaging-Guided Photothermal Therapy: A Narrative Review

Contrast Agents for Photoacoustic Imaging: A Review Focusing on the Wavelength Range

State-of-the-Art Preclinical Photoacoustic Imaging in Oncology: Recent Advances in Cancer Theranostics

A Photoacoustic Contrast Nanoagent with a Distinct Spectral Signature for Ovarian Cancer Management

In Vivo Photoacoustic Molecular Imaging of Breast Carcinoma with Folate Receptor-Targeted Indocyanine Green Nanoprobes

A review of clinical photoacoustic imaging: Current and future trends

Biomedical Photoacoustic Imaging for Molecular Detection and Disease Diagnosis: "Always‐On" and "Turn‐On" Probes

Photoacoustic Imaging: Contrast Agents and Their Biomedical Applications

Antibody-Conjugated Polymersomes with Encapsulated Indocyanine Green J-Aggregates and High Near-Infrared Absorption for Molecular Photoacoustic Cancer Imaging

Current Strategies of Photoacoustic Imaging Assisted Cancer Theragnostics toward Clinical Studies

Exogenous imaging contrast and therapeutic agents for intravascular photoacoustic imaging and image-guided therapy

Recent Development of Technology and Application of Photoacoustic Molecular Imaging Toward Clinical Translation

Integration of Multitargeted Polymer-Based Contrast Agents with Photoacoustic Computed Tomography: An Imaging Technique to Visualize Breast Cancer Intratumor Heterogeneity

Applications of Activatable Organic Photoacoustic Contrast Agents

Phthalocyanine-based Photoacoustic Contrast Agents for Imaging and Theranostics

Acoustic-based chemical tools for profiling the tumor microenvironment